• Rakesh Margam Governors State University



IoT, Inhalers, EHR


Effective management techniques are required for the widespread chronic respiratory disease known as asthma in order to reduce its negative effects on public health. Smart inhalers are a prime example of how the introduction of Internet of Things (IoT) technology has sparked creative solutions. In this essay, the seamless integration of IoT technology is used to elaborate on the transformational potential of smart inhalers in improving asthma management. The traditional approach to managing asthma relies on individualised prescription regimens that must be consistently followed. But obstacles including patient forgetfulness and insufficient real-time monitoring frequently prevent effective adherence, aggravating symptoms and lowering quality of life. Smart inhalers are the result of the confluence of IoT technology with asthma therapy, signalling a paradigm change. Smart inhalers, driven by IoT, offer a wide range of characteristics and signal a paradigm change in the treatment of asthma. (1) These gadgets can monitor medicine use, inhaler technique, and environmental triggers in real time since they include sensors and connection. Personalised therapy modifications are made possible by the real-time data creation that gives healthcare professionals insights into patient behaviour, adherence trends, and symptom development. The ability of smart inhalers to revolutionise medication adherence is one of their main benefits. (2)Patients are better able to maintain their regimens when they receive prompt guidance on how to use an inhaler and reminders to take prescription drugs as directed. The resultant decline in emergency room visits, hospital admissions, and asthma attacks is evidence of these devices' effectiveness. Healthcare professionals are empowered to quickly react and prevent the progression of symptoms thanks to the real-time data stream from smart inhalers. (3)Asthma care has advanced dramatically with the introduction of IoT-enabled smart inhalers, which are expected to improve asthma sufferers' medication compliance, symptom management, and overall quality of life. Predicted developments in smart inhaler technology, including artificial intelligence and predictive analytics, portend improved personalisation and therapeutic efficacy as the IoT environment changes. The promise of smart inhalers to reshape asthma care resonates deeply with the principles of patient education, engagement, and interdisciplinary collaboration among healthcare professionals, researchers, and technology developers, setting a promising trajectory for respiratory healthcare. (4)


I. Jansen EM, van de Hei SJ, Dierick BJH, Kerstjens HAM, Kocks JWH, van Boven JFM. Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers. J Thorac Dis. 2021 Jun 1;13(6):3846.

II. Margam R. The Importance of EHR in Revolutionizing Healthcare Delivery and Financial Success. Artic Int J Comput Trends Technol. 2023;71:52–5.

III. Vestbo J, Calverley P, Celli B, Ferguson G, Jenkins C, Jones P, et al. The TORCH (TOwards a Revolution in COPD Health) survival study protocol. Eur Respir J. 2004;24(2):206–10.

IV. Taylor TE, Muls HL, Costello RW, Reilly RB. Estimation of inhalation flow profile using audio-based methods to assess inhaler medication adherence. PLoS One. 2018 Jan 1;13(1).

V. Chan AHY, Stewart AW, Harrison J, Camargo CA, Black PN, Mitchell EA. The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: A randomised controlled trial. Lancet Respir Med. 2015 Mar 1;3(3):210–9.

VI. Krings JG, Sekhar TC, Chen V, Blake K V., Sumino K, James AS, et al. Beginning to Address an Implementation Gap in Asthma: Clinicians’ Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States. J Allergy Clin Immunol Pract. 2023 May 26;

VII. Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGeralde M, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008 Jan 1;31(1):143–78.

VIII. Alvarez-Perea A, Dimov V, Popescu FD, Zubeldia JM. The applications of eHealth technologies in the management of asthma and allergic diseases. Clin Transl Allergy. 2021 Sep 1;11(7):e12061.

IX. Margam R. Importance of Cybersecurity in Electronic Health Records. Int J Innov Sci Res Technol. 2023;8(7).

X. Gibson PG, McDonald VM. Management of severe asthma: targeting the airways, comorbidities and risk factors. Intern Med J. 2017 Jun 1;47(6):623–31.

XI. Kumar P, Sharma SK, Dutot V. Artificial intelligence (AI)-enabled CRM capability in healthcare: The impact on service innovation. Int J Inf Manage. 2023 Apr 1;69.

XII. Lidströmer N, Ashrafian H. Artificial Intelligence in Medicine. Artif Intell Med. 2022 Jan 1;1–1858.

XIII. Islam SMR, Kwak D, Kabir MH, Hossain M, Kwak KS. The internet of things for health care: A comprehensive survey. IEEE Access. 2015 Jun 1;3:678–708.

XIV. Minh Dang L, Piran MJ, Han D, Min K, Moon H. A Survey on Internet of Things and Cloud Computing for Healthcare. Electron 2019, Vol 8, Page 768. 2019 Jul 9;8(7):768.

XV. Noorbakhsh-Sabet N, Zand R, Zhang Y, Abedi V. Artificial Intelligence Transforms the Future of Health Care. Am J Med. 2019 Jul 1;132(7):795–801.

XVI. Mitchell M, Hedt-Gauthier BL, Msellemu D, Nkaka M, Lesh N. Using electronic technology to improve clinical care – results from a before-after cluster trial to evaluate assessment and classification of sick children according to Integrated Management of Childhood Illness (IMCI) protocol in Tanzania. BMC Med Inf Decis Mak. 2013;13:95.

XVII. Krebs P, Duncan DT. Health App Use Among US Mobile Phone Owners: A National Survey. JMIR mHealth uHealth. 2015 Nov 4;3(4):e101.

XVIII. Chrystyn H, Audibert R, Keller M, Quaglia B, Vecellio L, Roche N. Real-life inhaler adherence and technique: Time to get smarter! Respir Med. 2019 Oct 1;158:24–32.

XIX. Roche N, Dekhuijzen PNR. The evolution of pressurized metered-dose inhalers from early to modern devices. J Aerosol Med Pulm Drug Deliv. 2016 Aug 1;29(4):311–27.

XX. Hefnawy A, Herpin MJ, Easton M, Joshi S, Jordan D, Smyth HDC, et al. Design Validation of a Smart Inhaler Device with an Integrated Spacer for Enhanced Aerosolization Performance. J Pharm Innov. 2022 Aug 17;1–5.

XXI. Howard S, Lang A, Patel M, Sharples S, Shaw D. Electronic Monitoring of Adherence to Inhaled Medication in Asthma.


XXIII. Furst SJ, Hangekar R, Seelecke S. Practical Implementation of Resistance Feedback Measurement for Position Control of a Flexible Smart Inhaler Nozzle. ASME 2010 Conf Smart Mater Adapt Struct Intell Syst SMASIS 2010. 2011 Apr 4;2:205–13.

XXIV. Reddel HK, Bateman ED, Schatz M, Krishnan JA, Cloutier MM. A Practical Guide to Implementing SMART in Asthma Management. J allergy Clin Immunol Pract. 2022 Jan 1;10(1S):S31–8.

XXV. Chapman KR, Barnes NC, Greening AP, Jones PW, Pedersen S. Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal. Thorax. 2010 Aug;65(8):747–52.

XXVI. Krings JG, Gerald JK, Blake K V., Krishnan JA, Reddel HK, Bacharier LB, et al. A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma. Am J Respir Crit Care Med. 2023 Feb 15;207(4):390–405.

XXVII. Ioniuc I, Miron I, Lupu VV, Starcea IM, Azoicai A, Alexoae M, et al. Challenges in the Pharmacotherapeutic Management of Pediatric Asthma. Pharmaceuticals (Basel). 2022 Dec 18;15(12).

XXVIII. Zabczyk C, Blakey JD. The Effect of Connected “Smart” Inhalers on Medication Adherence. Front Med Technol. 2021;3.

XXIX. Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: A systematic review of the literature. Health Technol Assess (Rockv). 2001;5(26).

XXX. Chan AHY, Pleasants RA, Dhand R, Tilley SL, Schworer SA, Costello RW, et al. Digital Inhalers for Asthma or Chronic Obstructive Pulmonary Disease: A Scientific Perspective. Pulm Ther. 2021 Dec 1;7(2):345–76.

XXXI. Jansen EM, van de Hei SJ, Dierick BJH, Kerstjens HAM, Kocks JWH, van Boven JFM. Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: a narrative review of the clinical and economic case for smart inhalers. J Thorac Dis. 2021 Jun 1;13(6):3846–64.

XXXII. Honkoop P, Usmani O, Bonini M. The Current and Future Role of Technology in Respiratory Care. Pulm Ther. 2022 Jun 1;8(2):167–79.

XXXIII. Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, et al. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Health Technol Assess (Rockv). 2008;12(19):1–233.

XXXIV. Maken P, Gupta A, Gupta MK. A systematic review of the techniques for automatic segmentation of the human upper airway using volumetric images. Med Biol Eng Comput. 2023 Aug 1;61(8):1901–27.

XXXV. Sorino C, Negri S, Spanevello A, Visca D, Scichilone N. Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler. Eur J Intern Med. 2020 May 1;75:15–8.

XXXVI. Rakesh Margam. “Importance of Cybersecurity in Electronic Health Records.” Volume. 8 Issue. 7, July - 2023 International Journal of Innovative Science and Research Technology (IJISRT), ISSN - 2456-2165, PP :-24-28.

XXXVII. Rakesh Margam, Connecting Healthcare Ecosystems: The Journey of Interoperability, International Journal of Bioinformatics and Blockchain Technology (IJBBCT), 1(1), 2023, pp. 1–9 doi:

Additional Files



How to Cite

Rakesh Margam. (2024). SMART INHALERS: HARNESSING IOT FOR PRECISE ASTHMA MANAGEMENT. International Education and Research Journal (IERJ), 10(1).